Publicacións (50) Publicacións nas que participase algún/ha investigador/a

2015

  1. A laser-based technology for fabricating a soda-lime glass based microfluidic device for circulating tumour cell capture

    Colloids and Surfaces B: Biointerfaces, Vol. 134, pp. 363-369

  2. Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 201-206

  3. Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice

    Clinical and Translational Oncology, Vol. 17, Núm. 11, pp. 862-869

  4. Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction

    Clinical and Translational Oncology, Vol. 17, Núm. 11, pp. 856-861

  5. Aflibercept for metastatic colorectal cancer: Safety data from the Spanish named patient program

    Expert Opinion on Drug Safety, Vol. 14, Núm. 8, pp. 1171-1179

  6. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

  7. BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

    Scientific Reports, Vol. 5

  8. Bladder aspergillosis detected by urine cytology

    Diagnostic Cytopathology, Vol. 43, Núm. 5, pp. 403-406

  9. Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC)

    JOURNAL OF THORACIC ONCOLOGY, Vol. 10, Núm. 9 Sup2, pp. S657-S657

  10. Circulating miR-200c and miR-141 and outcomes in patients with breast cancer

    BMC Cancer, Vol. 15, Núm. 1

  11. Clinical guideline SEOM: hepatocellular carcinoma

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 988-995

  12. Clinical implications of epithelial cell plasticity in cancer progression

    Cancer Letters, Vol. 366, Núm. 1, pp. 1-10

  13. Colorectal cancer classification and cell heterogeneity: A systems oncology approach

    International Journal of Molecular Sciences, Vol. 16, Núm. 6, pp. 13610-13632

  14. Current controversies in the management of metastatic colorectal cancer

    Cancer Chemotherapy and Pharmacology, Vol. 76, Núm. 4, pp. 659-677

  15. Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling

    eLife, Vol. 4, Núm. JUNE2015

  16. Defining breast cancer intrinsic subtypes by quantitative receptor expression

    Oncologist, Vol. 20, Núm. 5, pp. 474-482

  17. Detection of circulating melanoma cells in choroidal melanocytic lesions Cancer

    BMC Research Notes, Vol. 8, Núm. 1

  18. El cáncer hereditario en mujeres

    Arbor: ciencia, pensamiento y cultura, Núm. 773

  19. Enzalutamide: A new prostate cancer targeted therapy against the androgen receptor

    Cancer Treatment Reviews, Vol. 41, Núm. 3, pp. 247-253

  20. Epirubicin plus cyclophosphamide followed by docetaxel versus epirubicin plus docetaxel followed by capecitabine as adjuvant therapy for node-positive early breast cancer: Results from the GEICAM/2003-10 study

    Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3788-3795